Tagged with Saudi

Saudi Arabia After almost two decades with MSD, Ashraf Mallak, managing director for the company in the GCC region, dives into the often-overlooked healthcare capabilities of the Gulf countries, including the fact that certain products approved by the US FDA can sometimes be available in the region in as little as one…

Saudi Arabia Medochemie’s Yasser Sabra gives a fascinating insight into the branded generic and value added medicine field today, including why the COVID-19 pandemic could lead to a reappraisal of medicine repurposing. Sabra also touches on the firm’s operations in the Middle East’s biggest market of Saudi Arabia, explaining why the Saudi…

Saudi Arabia As the Saudi pharma market – worth approximately USD 8.2 billion – continues to grow, so does the need for pharma companies to efficiently distribute their medicines inside the Kingdom. Here, we present four of the main trends at play in the Saudi distribution landscape, from market consolidation to centralised…

Saudi Arabia Dr Mona Obaid, chief medical officer for Lilly in Saudi Arabia, explains how the country’s Vision 2030 is shaping the pharma industry and society at large, Lilly’s role in increasing awareness of diabetes, and the opportunities for Saudi in regional clinical trials.   There is a huge opportunity ahead for…

MENA The Middle East and Africa (MEA) region is vast and is predominantly composed of emerging countries with varying levels of income and healthcare infrastructure. Here, three regional managers for pharma multinationals explain what MEA means to their global groups and their key areas of focus today.   Biogen: Awareness is…

Saudi Arabia Khaled Harb, general manager of Saudi distributor Abdulrehman Algosaibi, highlights the changing distribution landscape in Saudi Arabia, the importance of offering comprehensive solutions that go beyond traditional services, what the updated role of procurement body NUPCO means for the industry, and shares his perspective on the Vision 2030 transformation.  …

UAE Amgen MEA’s Mohamed Nasser* examines the current pharma commercialisation model, posits how the entire healthcare ecosystem’s rapid and effective response to COVID-19 could be replicable in other disease areas, and makes his predictions for the industry’s future direction.   Probably more than at any other time in history, the last…

Saudi Arabia In a recent royal decree, Saudi Arabia has appointed Fahad Al-Jalajel as its Minister of Health, replacing Dr Tawfiz Al-Rabia who had served since 2016. Here, we give a quick run-through of Al-Jalajel’s career thus far.   The holder of a bachelor’s degree in computer science from King Saud University,…

Saudi Arabia Recently appointed CEO of Saudi Chemical Company Holding’s Pharma Sector, Ismail Shehada is today drawing on 20+ years of Big Pharma experience to drive SCCH’s growing life sciences footprint in alignment with the Kingdom of Saudi Arabia’s Vision 2030 healthcare transformation. Shehada explains how SCCH is moving into third-party logistics…

Saudi Arabia Biogen’s manager for the Middle East, Africa, Russia & CIS, Turkey (MART), Ajai Sulekh, discusses the company’s five-pillar strategy to expand its footprint in the region, the importance of its newly established technical & scientific office in Saudi Arabia, and why the Kingdom is part of “almost every discussion” about…

Saudi Arabia Siemens Healthineers’ CEO for the Middle East and Southern and Eastern Africa, Ole Per Maloy, outlines the company’s different business models in the region, how it chooses partners in markets where Siemens Healthineers previously operated indirectly, and explains how the Varian acquisition will allow the organisation to provide comprehensive cancer…

Saudi Arabia Aspen’s regional CEO for the Middle East, North Africa & Turkey, Daniel Vella Friggieri, provides insights into how the South African company’s federated model and decentralized management system translates into differentiated portfolios across regions and significant networks of local CMO partners. After more than five years with Aspen in the…